发明名称 |
USE OF DRONEDARONE OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF PATIENTS WITH ARRHYTHMIA AND AN INCREASED CREATININE LEVEL DUE TO DRONEDARONE ADMINISTRATION |
摘要 |
Use of dronedarone or one of its pharmaceutically acceptable salts for preparing a medicament for the treatment of patients with arrhythmia, said patients having an increase of creatinine level due to dronedarone administration, said creatinine level increasing following dronedarone treatment initiation, said creatinine level increase reaching a plateau and being used as a new baseline, said creatinine level increase being reversible after dronedarone discontinuation. |
申请公布号 |
UA100883(C2) |
申请公布日期 |
2013.02.11 |
申请号 |
UA20100012809 |
申请日期 |
2009.04.28 |
申请人 |
SANOFI-AVENTIS |
发明人 |
CLAUDEL, SOPHIE;GAUDIN, CHRISTOPHE |
分类号 |
A61K31/343;A61K45/06;A61P9/06 |
主分类号 |
A61K31/343 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|